Pages that link to "Q34484071"
Jump to navigation
Jump to search
The following pages link to Immune mechanisms of allergen-specific sublingual immunotherapy (Q34484071):
Displaying 50 items.
- Evaluation of the Sublingual Route for Administration of Influenza H5N1 Virosomes in Combination with the Bacterial Second Messenger c-di-GMP (Q21090975) (← links)
- Sublingual immunotherapy for treating allergic conjunctivitis (Q24235657) (← links)
- Novel vaccine development strategies for inducing mucosal immunity (Q24607533) (← links)
- The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy (Q26822976) (← links)
- Induction of tolerance via the sublingual route: mechanisms and applications (Q27022140) (← links)
- Immunological mechanisms of allergen-specific immunotherapy (Q28265326) (← links)
- Basic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy (Q30276174) (← links)
- Molecular approach to allergy diagnosis and therapy (Q33822511) (← links)
- Antibody-mediated protection and the mucosal immune system of the genital tract: relevance to vaccine design (Q33913898) (← links)
- Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice (Q34286392) (← links)
- Treatment of grass pollen allergy: focus on a standardized grass allergen extract - Grazax®. (Q34606056) (← links)
- Modulation of dendritic cell innate and adaptive immune functions by oral and sublingual immunotherapy (Q34613611) (← links)
- A Lipopolysaccharide from Pantoea Agglomerans Is a Promising Adjuvant for Sublingual Vaccines to Induce Systemic and Mucosal Immune Responses in Mice via TLR4 Pathway (Q34669830) (← links)
- A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis (Q34726800) (← links)
- Sublingual immunotherapy in allergic rhinitis (Q35502433) (← links)
- Nasal mucosa derived-mesenchymal stem cells from mice reduce inflammation via modulating immune responses (Q35571577) (← links)
- Sublingual immunization with adenovirus F protein-based vaccines stimulates protective immunity against botulinum neurotoxin A intoxication (Q35722157) (← links)
- Immune tolerance by induced regulatory T cells in asthma (Q35895177) (← links)
- Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8( ) T cells and activating Foxp3( ) regulatory T cells. (Q35913679) (← links)
- Indoleamine 2,3-Dioxygenase Is Not a Pivotal Regulator Responsible for Suppressing Allergic Airway Inflammation through Adipose-Derived Stem Cells (Q36182258) (← links)
- CD28/CTLA-4--CD80/CD86 and ICOS--B7RP-1 costimulatory pathway in bronchial asthma (Q36346464) (← links)
- Sublingual Immunotherapy Induces Regulatory Function of IL-10-Expressing CD4( )CD25( )Foxp3( ) T Cells of Cervical Lymph Nodes in Murine Allergic Rhinitis Model (Q36355490) (← links)
- Sublingual vaccination with influenza virus protects mice against lethal viral infection (Q36446440) (← links)
- Sublingual immunotherapy in the treatment of children (Q36515380) (← links)
- Immunological mechanisms of sublingual immunotherapy (Q36515385) (← links)
- Future developments in sublingual immunotherapy (Q36515402) (← links)
- New insights in sublingual immunotherapy (Q36561244) (← links)
- Sublingual immunotherapy of allergic diseases (Q36583727) (← links)
- Tolerability of the SQ-standardised grass sublingual immunotherapy tablet in patients treated with concomitant allergy immunotherapy: a non-interventional observational study (Q36662274) (← links)
- The peanut allergy epidemic: allergen molecular characterisation and prospects for specific therapy. (Q36702194) (← links)
- Implication of nanoparticles/microparticles in mucosal vaccine delivery (Q36837152) (← links)
- Allergen immunotherapy for allergic respiratory diseases (Q36864947) (← links)
- Adverse reactions and tolerability of high-dose sublingual allergen immunotherapy (Q37070698) (← links)
- Latex allergy: a model for therapy. (Q37171082) (← links)
- Current immunological approaches for management of allergic rhinitis and bronchial asthma (Q37427490) (← links)
- Sublingual immunotherapy in children: an updated review (Q37488131) (← links)
- Mechanisms of sublingual immunotherapy (Q37502904) (← links)
- Immunomodulation of allergic disease (Q37561129) (← links)
- Therapeutic manipulation of immune tolerance in allergic disease (Q37567423) (← links)
- Immunotherapy in the treatment of food allergy. Does it have a future? (Q37600991) (← links)
- An immunological overview of allergen specific immunotherapy -- subcutaneous and sublingual routes (Q37625553) (← links)
- Role of Treg in immune regulation of allergic diseases. (Q37690644) (← links)
- T-cell responses induced by allergen-specific immunotherapy (Q37735267) (← links)
- Immunotherapy in asthma (Q37793242) (← links)
- Immunological mechanisms of sublingual allergen-specific immunotherapy (Q37830740) (← links)
- Adjuvants and Vector Systems for Allergy Vaccines (Q37870458) (← links)
- Clinical Improvement after Escalation for Sublingual Immunotherapy (SLIT) (Q37936946) (← links)
- New insights in mucosal vaccine development. (Q37956429) (← links)
- The mucosal vaccine quandary: intranasal vs. sublingual immunization against influenza. (Q38001862) (← links)
- Adjuvants for allergy vaccines (Q38055323) (← links)